These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epstein-Barr virus-positive mucocutaneous ulcers as a manifestation of methotrexate-associated B-cell lymphoproliferative disorders. Hashizume H; Uchiyama I; Kawamura T; Suda T; Takigawa M; Tokura Y Acta Derm Venereol; 2012 May; 92(3):276-7. PubMed ID: 22293895 [No Abstract] [Full Text] [Related]
3. Epstein-Barr virus-positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosis. Attard AA; Praveen P; Dunn PJ; James GJ Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Aug; 114(2):e37-9. PubMed ID: 22769419 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate-associated Epstein-Barr virus mucocutaneous ulcer: A case report and review of literature. Ravi PY; Sigamani E; Jeelani Y; Manipadam MT Indian J Pathol Microbiol; 2018; 61(2):255-257. PubMed ID: 29676371 [TBL] [Abstract][Full Text] [Related]
6. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis]. Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880 [TBL] [Abstract][Full Text] [Related]
7. EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression. Dojcinov SD; Venkataraman G; Raffeld M; Pittaluga S; Jaffe ES Am J Surg Pathol; 2010 Mar; 34(3):405-17. PubMed ID: 20154586 [TBL] [Abstract][Full Text] [Related]
8. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis. Maruani A; Wierzbicka E; Machet MC; Abdallah-Lotf M; de Muret A; Machet L J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S69-71. PubMed ID: 17938029 [TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus? Starkebaum G J Rheumatol; 2001 Dec; 28(12):2573-5. PubMed ID: 11764198 [No Abstract] [Full Text] [Related]
10. EBV-positive Mucocutaneous Ulcer With Small Lymphocytic Infiltration Mimicking Nonspecific Ulceration. Fujimoto M; Kaku Y; Hirata M; Usui S; Yamada Y; Haga H Am J Surg Pathol; 2021 May; 45(5):694-700. PubMed ID: 33739792 [TBL] [Abstract][Full Text] [Related]
11. [Spontaneous regression of immunodeficiency associated plasmablastic lymphoma related to methotrexate after decrease of dosage]. García-Noblejas A; Velasco A; Cannata-Ortiz J; Arranz R Med Clin (Barc); 2013 Jun; 140(12):569-70. PubMed ID: 23177304 [No Abstract] [Full Text] [Related]
12. Systemic EBV-Positive Methotrexate-Related Lymphoproliferative Disorder Associated With Skin Lesion Resembling EBV-Positive Mucocutaneous Ulcer: A Report of Two Cases. Fujimoto M; Takai T; Okada M; Okuno A; Haga H Am J Dermatopathol; 2021 Aug; 43(8):604-605. PubMed ID: 33606374 [No Abstract] [Full Text] [Related]
13. High prevalence of methotrexate use in patients with Epstein-Barr virus-positive mucocutaneous ulcer may cause confounding bias. Ramia de Cap M; Michaels PD Mod Pathol; 2021 Nov; 34(11):2084. PubMed ID: 33758325 [No Abstract] [Full Text] [Related]
14. Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome. Curry JL; Prieto VG; Jones DM; Vega F; Duvic M; Diwan AH J Cutan Pathol; 2011 Mar; 38(3):295-7. PubMed ID: 19889052 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous remission of methotrexate-associated lymphoproliferative disorder with Epstein-Barr virus type II latency. Matsuzaki Y; Minakawa S; Sagara C; Takiyoshi N; Nakano H; Sawamura D Eur J Dermatol; 2018 Oct; 28(5):693-694. PubMed ID: 30325313 [No Abstract] [Full Text] [Related]